ID
36094
Beschreibung
Study ID: 101468/198 Clinical Study ID: 101468/198 Study Title:An open, randomised, crossover, healthy volunteer study to compare the PK and tolerability of ropinirole as 3 different new formulations with the standard marketed formulation and to study the effects of a high fat meal on a new formulation Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The Study consists of a Screening, 5 Sessions each with 2 days and a Follow-up. This document contains the Dosing Details form. It has to be filled in for all sessions each for day 1.
Stichworte
Versionen (1)
- 15.04.19 15.04.19 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
15. April 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Comparison of pharmacokinetic and tolerability of ropinirole in healthy adults, 101468/198
Dosing Details
- StudyEvent: ODM
Beschreibung
Dosing Details
Alias
- UMLS CUI-1
- C0013227 (Pharmaceutical Preparations)
- SNOMED
- 763158003
- LOINC
- LP100609-9
- UMLS CUI-2
- C0178602 (Dosage)
- SNOMED
- 260911001
- LOINC
- LP7180-5
Beschreibung
00:00-23:59
Datentyp
time
Alias
- UMLS CUI [1,1]
- C0178602 (Dosage)
- SNOMED
- 260911001
- LOINC
- LP7180-5
- UMLS CUI [1,2]
- C0040223 (Time)
- SNOMED
- 410670007
- LOINC
- LP73517-2
Beschreibung
Dose checked and administered by
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1283174 (Checking (action))
- SNOMED
- 360160009
- LOINC
- LP35034-5
- UMLS CUI [1,2]
- C0178602 (Dosage)
- SNOMED
- 260911001
- LOINC
- LP7180-5
- UMLS CUI [1,3]
- C2826892 (Investigator Name)
- UMLS CUI [2,1]
- C0806914 (Medication administered)
- LOINC
- MTHU008310
- UMLS CUI [2,2]
- C2826892 (Investigator Name)
Beschreibung
Dose checked and witnessed by
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0682356 (Witnesses)
- UMLS CUI [1,2]
- C1283174 (Checking (action))
- SNOMED
- 360160009
- LOINC
- LP35034-5
- UMLS CUI [1,3]
- C0178602 (Dosage)
- SNOMED
- 260911001
- LOINC
- LP7180-5
Beschreibung
Comments
Datentyp
text
Alias
- UMLS CUI [1]
- C0947611 (Comment)
- LOINC
- LP72293-1
Ähnliche Modelle
Dosing Details
- StudyEvent: ODM
C0040223 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C2826892 (UMLS CUI [1,3])
C0806914 (UMLS CUI [2,1])
C2826892 (UMLS CUI [2,2])
C1283174 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
Keine Kommentare